Microbot Medical Inc.
About Microbot Medical Inc.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2015
- $116.9K
- Net income
- -$13.1M
- Total assets
- $81.5M
- Market cap
- $123.6M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Operating income
- -$14.7M
- Net income
- -$13.1M
- EPS (basic)
- $-0.29
- EPS (diluted)
- $-0.29
Balance sheet
- Total assets
- $81.5M
- Current assets
- $79.8M
- Total liabilities
- $4.0M
- Current liabilities
- $3.4M
- Shareholders’ equity
- $77.6M
Cash flow
- Operating cash flow
- -$13.0M
- Investing cash flow
- -$72.4M
- Financing cash flow
- $86.2M
- Net cash flow
- $810.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $123.6M
- EPS (diluted)
- $-0.29
- Shares outstanding
- 67.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 25, 1992
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $13.1M in FY2015.
- Trading 60% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Microbot Medical Inc..
Write a review
News about Microbot Medical Inc.
News & sentiment via Polygon.io
